Close
Close

Hepatitis C Virus-like Particles (HCV VLPs) (CAT#: VLP-046YF)

Datasheet
Recombinant Hepatitis C Virus-like Particles (HCV VLPs) are produced in Baculovirus/Insect cell expression system, assembled with HCV envelope 1 (E1) protein, HCV envelope 2 (E2) protein and p7 protein. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material which makes them non-infectious, unable to replicate and enhance the safety during manufacture and administration. HCV VLPs can be used in the development of HCV diagnostics and in vaccine development and R&D (including use as an immunogen).

Product Specifications

  • Structural Proteins
  • HCV envelope 1 (E1) protein, HCV envelope 2 (E2) protein and p7 protein
  • Expression Systems
  • Baculovirus/Insect cell expression system (please specify if other expression system is needed)
  • Form
  • Liquid
  • Alternative Names
  • Hepatitis C Virus-like Particles; Hepatitis C VLPs; Hepatitis C Virus; HCV VLPs; Virus-like Particles; VLPs
  • Storage
  • Store at -80 °C long term. Avoid repeated freeze/thaw cycles.

Virus Background

  • Virus Family
  • Flaviviridae
  • Virus Species
  • Hepacivirus C
  • Virus Overview
  • The hepatitis C virus (HCV) is a small (55-65 nm in size), enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. The hepatitis C virus is the cause of hepatitis C and some cancers such as liver cancer (hepatocellular carcinoma, abbreviated HCC) and lymphomas in humans.
  • Virus Structure
  • Enveloped, positive-sense, single-stranded RNA virus
  • Related Disease
  • Hepatitis C and some cancers

Customer reviews and Q&As    

Related Products
Online Inquiry
CONTACT US
USA:
Europe:
Germany:
Call us at:
USA:
UK:
Germany:
Fax:
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2024 Creative Biolabs. | Contact Us